| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2000 | CN1240639A Composition of olefin copolymer comprising controlled crystallization and use of such coplymer |
| 01/12/2000 | CN1048296C Process for preparation of 9-amino camptothecin |
| 01/12/2000 | CN1048249C Aminopyrrolizinetone compounds |
| 01/12/2000 | CN1048247C Neuroprotective chroman compounds |
| 01/12/2000 | CN1048245C 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivs., their preparing process and anti-ulcer composition contg. same |
| 01/12/2000 | CN1048242C 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid deriv. and its preparing process, and intermediate compound |
| 01/12/2000 | CN1048241C Vitamin D analogues, their preparing process, pharmaceutical composition contg. same and use thereof |
| 01/12/2000 | CN1048240C Process for preparing 7-substed-9-substed. amino-6-demethyl-6-deoxytetracyclines |
| 01/12/2000 | CN1048167C Chinese medicine ointment for treating gynaopathly |
| 01/12/2000 | CN1048159C Method for preparing pharmaceutical composition contg. imidazolyl-alkenoic acid |
| 01/12/2000 | CN1048158C Use of apigenin-A in preparation of medicine for prevention and treatment of diseases caused by cerebral ischemia |
| 01/11/2000 | US6013837 Aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides |
| 01/11/2000 | US6013828 Processes and intermediates useful to make antifolates |
| 01/11/2000 | US6013823 Trans-pentavalent 2-15-deoxy-16-hydroxy-16-methyl-PGE1 methyl ester (B-407) |
| 01/11/2000 | US6013814 Vitamin D analogues |
| 01/11/2000 | US6013809 Analgesics |
| 01/11/2000 | US6013807 Amidation to produce compound having low toxicity and antitumor activity |
| 01/11/2000 | US6013796 Simplification, efficiency, nontoxic |
| 01/11/2000 | US6013792 Matrix metalloprotease inhibitors |
| 01/11/2000 | US6013786 Nucleotide sequences used as inhibitors of the oncogenic action of the encoded protein; antitumor agents |
| 01/11/2000 | US6013778 Process for the preparation of azithromycin |
| 01/11/2000 | US6013678 Administering to a patient suffering from congestive heart failure a therapeutically effective amount of 5,6-diisobutyroyloxy-2-methylaminotetralin or a salt |
| 01/11/2000 | US6013675 Therapeutic substituted guanidines |
| 01/11/2000 | US6013674 Indenone amide derivatives, useful for for the inhibition of leukocyte adherence to endothelial cells; useful in the treatment of inflammatory diseases, as arthritis, asthama, psoriasis, respiratory distress syndrome, stroke and ulcer |
| 01/11/2000 | US6013673 Naphthyloxy acetic acid derivatives |
| 01/11/2000 | US6013672 Administering to an individual suffering from head, spinal cord trauma, stroke and epilepsy a therapeutically effective dose of a metabotropic glutamate receptor agonist |
| 01/11/2000 | US6013670 Administering c1-c6 alkanoyl carnitine or salt to treat chronic inflammatory bowel disease |
| 01/11/2000 | US6013668 Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile |
| 01/11/2000 | US6013667 Benzenesulfonylamine compounds, process for preparing them and pharmaceutical compositions |
| 01/11/2000 | US6013665 Administering to a animal a triglyceride containg atleast 33 to 70 weight% medium acyl chain having 4 to 12 carbon atom, 30 to 67 weight % long acyl chain having more than 12 carbon atom, an equivalent carbon number 30 to 48 |
| 01/11/2000 | US6013663 Dithiolan derivatives, their preparation and their therapeutic effect |
| 01/11/2000 | US6013659 Methods of reducing tumor colony number using novel benzothiazole compounds |
| 01/11/2000 | US6013658 Animal growth regulators |
| 01/11/2000 | US6013657 Pharmaceutical compositions containing mupirocin |
| 01/11/2000 | US6013656 2-(arylalkenyl) azacycloalkane derivatives as ligands for sigma receptors |
| 01/11/2000 | US6013655 Hypotensive agents; respiratory system diisorders |
| 01/11/2000 | US6013650 Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands |
| 01/11/2000 | US6013649 Bond disorders; autoimmune diseases; antitumor agents |
| 01/11/2000 | US6013648 Immunomodulators |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013646 Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/11/2000 | US6013645 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/11/2000 | US6013644 Aids therapy |
| 01/11/2000 | US6013642 Use of estrone derivatives as steroid sulphatase inhibitors |
| 01/11/2000 | US6013641 Inhibiting lymphocytes |
| 01/11/2000 | US6013640 Antiischemic agents |
| 01/11/2000 | US6013639 G cap-stabilized oligonucleotides |
| 01/11/2000 | US6013637 Anti-acne method and composition |
| 01/11/2000 | US6013636 Mixture with vegetable oil and cosolvent |
| 01/11/2000 | US6013635 Treatment of C. difficile toxin B associated conditions |
| 01/11/2000 | US6013634 Solid support matrices containing a toxin binding oligosaccharide |
| 01/11/2000 | US6013632 Administration of one or more of glutathione, its disulfide dimer, ascorbate-2-phosphate, or n-acetyl-l-cysteine, with or without antioxidants |
| 01/11/2000 | US6013626 To inhibit the proliferation of mammalian cells; antitumor agents |
| 01/11/2000 | US6013622 Method of regulating appetite and metabolism |
| 01/11/2000 | US6013621 Administering to patient an agent that inhibits the dephosphorylation of thr34-phosphorylated dopamine- and cyclic amp-regulated phosphoprotein wherein the agent inhibits calcineurin by binding to calcineurin |
| 01/11/2000 | US6013619 Applying gas positive end-expiratory pressure with ventilator into lung section of mammal, instilling lavage composition containing dilute surfactant in a pharmaceutically acceptable aqueous medium into lung, removing pulmonary fluid |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013487 Chimeric RNA molecules generated by trans-splicing |
| 01/11/2000 | US6013464 Human PAK65 |
| 01/11/2000 | US6013463 Diagnostic test kit for detecting campylobacter infection; for diagnosis of peptic ulcer disease or gastrointestinal cancer |
| 01/11/2000 | US6013458 Conformationally constrained compounds which mimic the secondary structure of biologically active peptides and proteins; for screening libraries |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013448 Pancreas-derived serpin |
| 01/11/2000 | US6013281 Method of making a pharmaceutical dosage form comprising a proton pump inhibitor |
| 01/11/2000 | US6013280 Dosage of an analgesic agent and one or more polymeric solubizing agent containing a diblock copolymer of ethylene oxide and propylene oxide; improved dissolution and shorter time to maximum plasma concentration |
| 01/11/2000 | US6013278 Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/11/2000 | US6013277 Compositions for topical treatment of erectile impotence |
| 01/11/2000 | US6013273 For the treatment of endotoxic shock, enterally administering to a human or other mammal in need of such a treatment an effective amount of choline for reducing endotoxin-induced injucry or mortality |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | US6013251 Antiviral against human immuno deficiency virus (hiv), cytomegalovirus, herpes simplex virus (hsv) |
| 01/11/2000 | US6013244 21-(2-oxo-tetrahydrofuran)-thio pregnane derivatives, a process for their production and pharmaceutical compositions containing them |
| 01/11/2000 | US6013240 Nucleic acid containing composition, preparation and uses of same |
| 01/11/2000 | US6012375 Aircraft infrared guided defense missile system |
| 01/11/2000 | CA2247114C Liquid oral compositions comprising a calcium compound and an acidulant |
| 01/11/2000 | CA2195027C Hiv protease inhibitors useful for the treatment of aids |
| 01/11/2000 | CA2180754C Heteroaryl-substituted deoxy glycero-phosphoethanolamines |
| 01/11/2000 | CA2162001C Salicylic acid derivative used for the stabilization of an oil-in-water emulsion |
| 01/11/2000 | CA2150832C Antibiotic formulation and use for bacterial infections |
| 01/11/2000 | CA2065311C Solid matrix system for transdermal drug delivery |
| 01/11/2000 | CA2052577C Therapeutic uses of eicosapentaenoic acid |
| 01/11/2000 | CA2018137C L-carnitine magnesium citrate |
| 01/07/2000 | CA2276910A1 Novel cosmetic compositions comprising a film-forming polymer |
| 01/06/2000 | WO2000000644A1 Uses of dna-pk |
| 01/06/2000 | WO2000000618A2 Polyketides and their synthesis |
| 01/06/2000 | WO2000000599A2 Composition for the induction of apoptosis in target cells |
| 01/06/2000 | WO2000000514A2 Synthetic spiroketal pyranes as potent anti-cancer agents |
| 01/06/2000 | WO2000000501A1 ARYL PHOSPHATE DERIVATIVES OF d4T HAVING ANTI-HIV ACTIVITY |
| 01/06/2000 | WO2000000500A2 Polyketides and their synthesis |
| 01/06/2000 | WO2000000492A1 FINE POWDER OF L-α-AMINOADIPIC ACID DERIVATIVE, ORAL SOLID PREPARATIONS CONTAINING THE SAME, AND METHOD FOR TREATMENT OF BULK POWDERS |
| 01/06/2000 | WO2000000491A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents |
| 01/06/2000 | WO2000000489A2 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 01/06/2000 | WO2000000488A1 Muscarinic antagonists |
| 01/06/2000 | WO2000000487A1 5-ht1f agonists |
| 01/06/2000 | WO2000000484A1 Substituted benzopyran derivatives and their use as anticonvulsants |
| 01/06/2000 | WO2000000483A2 Tubulin binding compounds (cobra) |
| 01/06/2000 | WO2000000482A1 1-(benzothiazol-2-yl)-4-(1-phenylmethyl)piperazines: dopamine receptor subtype specific ligands |
| 01/06/2000 | WO2000000477A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 01/06/2000 | WO2000000473A1 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 01/06/2000 | WO2000000470A1 Amino acid derivatives and drugs containing the same as the active ingredient |
| 01/06/2000 | WO2000000469A2 Alkyl ketones as potent anti-cancer agents |